TPSF
MRNA icon

Texas Permanent School Fund’s Moderna MRNA Stock Holding History

Texas Permanent School Fund’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-68,575
Closed -$7.31M – 878
2024
Q1 		$7.31M Buy
68,575
+171
+0.2% +$17.2K 0.06% 356
2023
Q4 		$6.8M Sell
68,404
-18
-0% -$1.51K 0.06% 352
2023
Q3 		$7.07M Sell
68,422
-329
-0.5% -$36.7K 0.07% 280
2023
Q2 		$8.35M Sell
68,751
-131
-0.2% -$17.5K 0.08% 230
2023
Q1 		$10.6M Buy
68,882
+21,939
+47% +$3.62M 0.11% 150
2022
Q4 		$8.43M Sell
46,943
-660
-1% -$108K 0.13% 128
2022
Q3 		$5.63M Buy
47,603
+1,895
+4% +$288K 0.09% 202
2022
Q2 		$6.53M Sell
45,708
-45
-0.1% -$6.43K 0.1% 168
2022
Q1 		$7.88M Sell
45,753
-2,830
-6% -$476K 0.11% 154
2021
Q4 		$12.3M Sell
48,583
-5,667
-10% -$1.66M 0.15% 98
2021
Q3 		$20.9M Buy
+54,250
New +$20M 0.26% 58

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Texas Permanent School Fund's MRNA Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Moderna (MRNA) in Q2 2024, closing a stake of 68,575 shares — an estimated $7.31M sold.

Texas Permanent School Fund first reported a position in MRNA in Q3 2021 and held it in 11 quarters. The position peaked at $20.9M in Q3 2021. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 68,575 Moderna shares in Q2 2024, an estimated $7.31M.
  • Texas Permanent School Fund first reported a position in Moderna in Q3 2021 and held it in 11 quarters.
  • Texas Permanent School Fund's Moderna position peaked at $20.9M in Q3 2021.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.